Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Phenylalanine-specific permease (PheP) is a high-affinity membrane transporter primarily characterized in bacteria such as Escherichia coli (1, 8). It belongs to the amino acid-polyamine-organocation (APC) family and functions as a proton-coupled symporter, utilizing the proton motive force to actively transport L-phenylalanine and, to a lesser extent, L-tyrosine into the cytoplasm (1, 15). While PheP is not a human protein, it has emerged as a significant therapeutic component in the field of synthetic biology and live bacterial therapeutics (24, 26). Specifically, engineered strains like SYNB1618 and SYNB1934 utilize overexpressed PheP to facilitate the rapid uptake of dietary phenylalanine from the gastrointestinal tract into the bacteria, where it is subsequently degraded by enzymes like phenylalanine ammonia lyase (PAL) to treat phenylketonuria (PKU) (32, 36). Additionally, PheP is being explored as a potential antimicrobial target, as its inhibition may attenuate the growth and virulence of pathogens such as Staphylococcus aureus (25).
Proton-coupled symport of phenylalanine across the cell membrane
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Phenylalanine-specific permease (PheP) (PheP).